Clinical Trial Update: Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to assess the addition of lansoprazole to treatment for idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: RECRUITING